See more : Xinji Shaxi Group Co., Ltd (3603.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Allegra Orthopaedics Limited (AMT.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allegra Orthopaedics Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- QC Copper and Gold Inc. (QCCUF) Income Statement Analysis – Financial Results
- Guangdong Electric Power Development Co., Ltd. (200539.SZ) Income Statement Analysis – Financial Results
- Greatwalle Inc. (8315.HK) Income Statement Analysis – Financial Results
- Isras Investment Company Ltd (ISRS.TA) Income Statement Analysis – Financial Results
- Yamada Holdings Co., Ltd. (9831.T) Income Statement Analysis – Financial Results
Allegra Orthopaedics Limited (AMT.AX)
About Allegra Orthopaedics Limited
Allegra Orthopaedics Limited designs, sells, and distributes medical device products in Australia and New Zealand. It operates in two segments, Orthopedics Division and Innovation Division. The company provides adult and adolescent clavicle fixation systems; a range of symmetrical and asymmetrical offsets for shoulder; and StripEase, distal radius systems, compression screws, hand fracture systems, ulna shortening plates, and modular ceramic or CoCr heads for heads. It also offers reconstruction prosthesis, modular tumor and revision system, partial pelvis replacement, standard C cementless stem, revision cup, hip acetabular cup system, IP acetabular cup, ceramic prosthesis heads, and CoCrMo prosthesis heads, as well as cemented femoral stem, unipolar head, and cup resector; ActiveKnee, a total knee replacement prosthesis and knee distal first instruments; and foot and ankle products, such as total ankle replacement systems, DF toe, A-curve handles, screws, activ fuse, and plating system. In addition, the company provides sawblades and kirschner wires and pins. Further, it offers NanoFx, a solution for microfracture procedure; and instrument sets, including post-surgery rehabilitation, shoulder surgery, direct anterior approach, PCL protector, and revision surgery instrument. The company was formerly known as Advanced Surgical Design & Manufacture Limited and changed its name to Allegra Orthopaedics Limited in November 2014. Allegra Orthopaedics Limited was incorporated in 1994 and is based in Lane Cove West, Australia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 691.29K | 947.77K | 4.50M | 5.01M | 5.12M | 5.24M | 6.02M | 5.99M | 8.53M | 8.79M | 7.72M | 8.51M | 7.20M | 7.31M | 6.19M | 6.82M |
| Cost of Revenue | 13.92K | 287.80K | 1.87M | 2.11M | 1.57M | 1.41M | 1.57M | 1.66M | 3.56M | 3.26M | 3.31M | 3.52M | 3.29M | 3.39M | 1.67M | 2.47M |
| Gross Profit | 677.38K | 659.97K | 2.63M | 2.90M | 3.55M | 3.83M | 4.45M | 4.33M | 4.98M | 5.53M | 4.41M | 5.00M | 3.90M | 3.92M | 4.52M | 4.34M |
| Gross Profit Ratio | 97.99% | 69.63% | 58.36% | 57.85% | 69.40% | 73.12% | 73.96% | 72.28% | 58.32% | 62.92% | 57.11% | 58.70% | 54.23% | 53.67% | 73.01% | 63.71% |
| Research & Development | 1.37M | 1.73M | 2.32M | 2.55M | 1.72M | 1.23M | 898.30K | 1.34M | 1.58M | 1.39M | 1.15M | 1.30M | 1.95M | 752.00K | 180.89K | 131.84K |
| General & Administrative | 1.09M | 1.10M | 1.81M | 1.77M | 1.67M | 1.88M | 1.74M | 2.42M | 2.49M | 2.25M | 2.04M | 2.32M | 3.15M | 2.09M | 3.26M | 2.08M |
| Selling & Marketing | 0.00 | 753.86K | 860.49K | 923.49K | 1.00M | 1.32M | 1.21M | 1.73M | 1.90M | 1.96M | 1.57M | 1.65M | 1.74M | 1.16M | 407.63K | 489.26K |
| SG&A | 1.09M | 814.14K | 2.67M | 2.66M | 2.68M | 3.20M | 2.94M | 4.15M | 4.39M | 4.21M | 3.60M | 3.96M | 4.89M | 3.25M | 3.67M | 2.57M |
| Other Expenses | 0.00 | 1.08M | 1.96M | 1.27M | 1.36M | 1.01M | 1.75M | 1.63M | 1.21M | 817.00K | 680.00K | 186.00K | 161.00K | 178.00K | 155.00K | 148.69K |
| Operating Expenses | 2.46M | 2.55M | 5.00M | 5.22M | 4.39M | 4.43M | 3.84M | 6.30M | 5.67M | 5.60M | 4.63M | 6.20M | 7.88M | 5.13M | 6.16M | 4.31M |
| Cost & Expenses | 2.48M | 2.83M | 6.87M | 7.33M | 5.96M | 5.84M | 5.41M | 7.96M | 9.23M | 8.86M | 7.94M | 9.72M | 11.17M | 9.13M | 7.83M | 6.78M |
| Interest Income | 134.00 | 8.00 | 536.00 | 2.19K | 5.25K | 7.96K | 111.29K | 68.27K | 158.71K | 227.98K | 270.00K | 10.00K | 19.00K | 18.00K | 69.20K | 125.34K |
| Interest Expense | 301.04K | 134.44K | 13.23K | 10.15K | 0.00 | 7.96K | 111.29K | 68.27K | 158.71K | 228.00K | 270.00K | 284.00K | 230.00K | 132.00K | 99.95K | 106.26K |
| Depreciation & Amortization | 241.91K | 269.41K | 579.94K | 517.62K | 464.63K | 288.93K | 360.39K | 290.67K | 773.76K | 770.12K | 997.00K | 941.00K | 1.04M | 1.12M | 803.15K | 625.36K |
| EBITDA | -2.23M | -1.83M | -1.85M | -1.85M | -2.20M | -258.52K | 900.57K | -1.45M | -218.92K | 698.14K | 795.00K | 872.00K | -1.72M | 619.00K | -734.34K | 914.61K |
| EBITDA Ratio | -323.26% | -268.68% | -41.13% | -36.91% | -11.23% | -4.93% | 14.95% | -10.78% | -2.57% | 7.94% | 8.52% | 10.25% | -23.96% | 16.92% | -10.00% | 13.68% |
| Operating Income | -1.79M | -2.83M | -2.37M | -2.31M | -840.75K | -596.18K | 612.34K | -1.16M | -992.68K | -71.97K | -339.00K | -69.00K | -2.76M | -505.00K | -1.42M | 307.14K |
| Operating Income Ratio | -258.27% | -299.05% | -52.63% | -46.17% | -16.42% | -11.37% | 10.17% | -19.29% | -11.63% | -0.82% | -4.39% | -0.81% | -38.35% | -6.91% | -22.98% | 4.51% |
| Total Other Income/Expenses | -300.91K | -1.01M | 603.34K | 796.17K | 5.25K | -7.96K | -111.29K | -879.26K | 137.63K | -227.98K | -149.00K | 853.00K | -230.00K | 1.19M | 8.57K | 149.88K |
| Income Before Tax | -2.09M | -2.90M | -1.77M | -1.52M | -835.51K | -604.14K | 501.05K | -2.04M | -855.06K | -299.95K | -488.00K | -353.00K | -2.99M | -20.00K | -1.64M | 182.99K |
| Income Before Tax Ratio | -301.80% | -306.03% | -39.23% | -30.29% | -16.32% | -11.52% | 8.32% | -33.96% | -10.02% | -3.41% | -6.32% | -4.15% | -41.54% | -0.27% | -26.46% | 2.69% |
| Income Tax Expense | 0.00 | -884.77K | -1.19M | -353.44K | -524.50K | -545.21K | -261.95K | -479.22K | 0.00 | 0.00 | 0.00 | -180.00K | 276.00K | 444.00K | -612.74K | 2.99K |
| Net Income | -3.65M | -2.54M | -578.85K | -1.17M | -835.51K | -604.14K | 501.05K | -2.04M | -855.06K | -299.95K | -488.00K | -173.00K | -3.27M | -464.00K | -1.02M | 180.01K |
| Net Income Ratio | -527.67% | -267.50% | -12.86% | -23.24% | -16.32% | -11.52% | 8.32% | -33.96% | -10.02% | -3.41% | -6.32% | -2.03% | -45.38% | -6.35% | -16.56% | 2.64% |
| EPS | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | 0.01 | -0.03 | -0.01 | -0.01 | -0.01 | 0.00 | -0.08 | -0.01 | -0.03 | 0.00 |
| EPS Diluted | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | 0.01 | -0.03 | -0.01 | -0.01 | -0.01 | 0.00 | -0.08 | -0.01 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 182.40M | 104.46M | 104.37M | 99.56M | 99.56M | 94.25M | 70.88M | 63.59M | 57.30M | 43.47M | 38.42M | 39.26M | 39.26M | 39.26M | 39.26M | 37.11M |
| Weighted Avg Shares Out (Dil) | 104.46M | 104.46M | 104.37M | 99.56M | 99.56M | 94.25M | 70.88M | 63.59M | 57.30M | 43.75M | 38.42M | 39.26M | 39.26M | 39.26M | 39.26M | 38.50M |
Source: https://incomestatements.info
Category: Stock Reports